Table 2.
Analysis | SNP | Case/Control | Case | Control | P | OR (95%CI) |
---|---|---|---|---|---|---|
All subjects adjusted for PC1, PC2, PC3 | rs9934438 | 1496/993 | 0.136 | 0.093 | 0.0029† | 1.34 (1.11–1.62) |
rs9923231 | 1496/993 | 0.135 | 0.093 | 0.0032† | 1.34 (1.10–1.62) | |
Chinese subgroup | rs9934438 | 1022/809 | 0.123 | 0.099 | 0.020‡ | 1.28 (1.04–1.58) |
rs9923231 | 1022/809 | 0.122 | 0.099 | 0.028‡ | 1.27 (1.03–1.56) | |
Korean/Japanese subgroup | rs9934438 | 260/67 | 0.102 | 0.052 | 0.076‡ | 2.06 (0.91–4.64) |
rs9923231 | 260/67 | 0.102 | 0.045 | 0.043‡ | 2.38 (1.00–5.67) | |
Southeast Asian subgroup | rs9934438 | 112/7 | 0.290 | 0.071 | 0.076‡ | 5.31(0.68–41.46) |
rs9923231 | 112/7 | 0.290 | 0.071 | 0.076‡ | 5.31 (0.68–41.46) |
By logistic regression with first three principal components derived from Immunochip markers as covariates.
By chi-square test.